Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 5.92 0.3 (5.34%) Market Cap: 839.71 Mil Enterprise Value: 780.08 Mil PE Ratio: 0 PB Ratio: 2.43 GF Score: 74/100

Q3 2023 Maravai LifeSciences Holdings Inc Earnings Call Transcript

Nov 07, 2023 / 10:00PM GMT
Release Date Price: $6.88 (+0.58%)
Operator

Ladies and gentlemen, thank you for standing by. My name is Tammy, and I will be your conference operator today. At this time, I would like to welcome everyone to the Third Quarter 2023 Maravai LifeSciences Earnings Conference Call. (Operator Instructions)

I would now like to turn the conference over to Ms. Deb Hart. Please go ahead.

Debra Hart
Maravai LifeSciences Holdings, Inc. - Senior Director of IR

Good afternoon, everyone. Thanks for joining us on our third quarter 2023 earnings call. Our press release and the slides that accompany today's call are posted on our website and are available at investors.maravai.com.

As you can see on the agenda on Slide 2, joining me today are Trey Martin, Chief Executive Officer; and Kevin Herde, Chief Financial Officer. Drew Burch, President of Nucleic Acid Production, and Becky Buzzeo, our Executive Vice President and Chief Commercial Officer, will join the call for the question-and-answer session following our prepared remarks.

We remind you management will make forward-looking statements,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot